3Q EARNINGS: Biogen's MS pill Tecfidera blows away estimates, fuels overall sales growth

 
• By Brett Chase
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapy Areas